New ESRD bundled payment system considered

Article Overview

This piece covers early federal consideration of a bundled or prospective payment approach for End Stage Renal Disease (ESRD) care, along with Medicare’s concurrent review of coverage issues tied to anemia drugs used in dialysis and cancer treatment contexts. It is relevant to reimbursement professionals, renal care providers, and coders following Medicare policy, payment reform, and coverage developments. The article also touches on congressional interest in how savings from payment changes might affect physician fee schedule pressures.